These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 73438)

  • 1. Cell-mediated hypersensitivity in multiple sclerosis and other neurological diseases.
    Minderhoud JM; Mourik J; Teelken AW
    Clin Neurol Neurosurg; 1977; 80(1):22-32. PubMed ID: 73438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hypersensitivity to human encephalitogenic protein as assayed by agarose leucocyte migration in multiple sclerosis patients.
    Clanet M; Kuhlein E; Rascol A; Abbal M; Ohayon E
    J Neurol Sci; 1979 Jul; 42(2):203-13. PubMed ID: 90126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte sensitivity to brain fractions in neurological diseases.
    Alvord EC; Hsu PC; Thron R
    Arch Neurol; 1974 Apr; 30(4):296-9. PubMed ID: 4816833
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis.
    Ilyas AA; Davison AN
    J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperreactivity to myelin basic protein in multiple sclerosis.
    Eggers AE; Tarmin L; Plank CR; Gamboa ET
    J Neurol Sci; 1981; 52(2-3):385-90. PubMed ID: 6171620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
    Sheremata W; Woods DD; Moscarello MA
    Adv Exp Med Biol; 1978; 100():501-11. PubMed ID: 80948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. Variable effect of the antigen in a large dose range, with a literature review.
    Källén B; Nilsson O; Thelin C
    Acta Neurol Scand; 1977 Jan; 55(1):33-46. PubMed ID: 65893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
    Sheremata W; Eylar EH; Cosgrove JB
    J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.
    Colby SP; Sheremata W; Bain B; Eylar EH
    Neurology; 1977 Feb; 27(2):132-9. PubMed ID: 556829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis.
    Frick E
    J Neurol Sci; 1982; 57(1):55-66. PubMed ID: 6185643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis.
    Møller-Larsen A; Haahr S; Hansen HJ
    J Neuroimmunol; 1987 Jan; 13(3):273-82. PubMed ID: 2432085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of measles virus to encephalitogenic factor with reference to the aetiopathogenesis of multiple sclerosis.
    McDermott JR; Field EJ; Caspary EA
    J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):282-7. PubMed ID: 4133588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of antibody-dependent lymphocyte cytotoxicity against cerebral tissue constituents in multiple sclerosis. Studies with basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E; Stickl H
    Acta Neurol Scand; 1982 Jan; 65(1):30-7. PubMed ID: 6175158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct macrophage migration inhibition test applied in man.
    Teelken AW; Minderhoud JM
    Clin Exp Immunol; 1976 Apr; 24(1):26-32. PubMed ID: 59649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases.
    Górny MK; Wróblewska Z; Pleasure D; Miller SL; Wajgt A; Koprowski H
    Acta Neurol Scand; 1983 Jun; 67(6):338-47. PubMed ID: 6193672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte response depressive factor in multiple sclerosis.
    Field EJ; Caspary EA
    Br Med J; 1971 Nov; 4(5786):529-32. PubMed ID: 5128207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mediators of delayed hypersensitivity (lymphokines) in vitro in multiple sclerosis and in other nervous system diseases].
    Cendrowski W
    Neurol Neurochir Pol; 1974; 8(1):91-5. PubMed ID: 4601565
    [No Abstract]   [Full Text] [Related]  

  • 19. Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E
    Eur Neurol; 1988; 28(3):120-5. PubMed ID: 2454817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
    Colby-Germinario SP; Sheremata W; Bain B; Eylar EH
    J Neurol Sci; 1977 Aug; 33(1-2):111-29. PubMed ID: 71338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.